Phase Ib / II Trial Evaluating the Association Myocet - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Carboplatin (Primary) ; Doxorubicin liposomal (Primary)
- Indications Ovarian cancer
- Focus Biomarker; Therapeutic Use
- Acronyms Gineco; MYCA
- 14 Nov 2018 Results published in the Gynecologic Oncology
- 11 Oct 2016 Status changed from active, no longer recruiting to completed according to the results presented at the 41st European Society for Medical Oncology Congress.
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress.